Pharming-yhtiöt ovat erikoistuneet tuottamaan lääkevalkuaisai-neita eläinten maitoon. Suomessa toimiva Pharming Oy on hollantilaisen Pharming BV:n täysin omistama tytäryhtiö. Pharming-yhtiöihin kuuluu vielä äskettäin Belgiaan perustettu Pharming NV. Yhtiöt soveltavat modernin biotekniikan, lähinnä molekyylibiologian ja alkioviljelytekniikan uusimpia saavutuksia, joiden avulla ihmisen lääkeproteiinit saadaan erittymään tuotantoeläimen maitoon. Tuotekehityksessä lähinnä markkinoita ovat ihmisen laktoferriini, ihmisen kollageenit ja ihmisen alfa-glukosidaasi.%Pharming is an independent European bio-pharmaceutical company, focusing on the development of human health care products from milk. The company has developed proprietary technology to generate transgenic animals capable of producing biomedical proteins in their milk at high levels. Pharming was the first in the world to generate dairy cattle containing an extra piece of genetic information allowing the production of a human protein in milk. The company has established a strong, worldwide, patent position. Pharming Oy is the Finnish subsidiary of the Dutch parent company, Pharming BV, headquartered in Leiden. Recently a new daughter company, Pharming NV, located in Geel, Belgium, was established. The products closest to the market launch include human alpha-glucosidase for the treatment of muscular disorder, or Pompe's Disease; human lactoferrin, an anti-infective, targeted at the treatment of infections in im-munocompromised patients, human collagen type Ⅰ, targeted at tissue repair, including the treatment of wounds, bone fractures and urinary stress incontinence; and human collagen type Ⅱ, targeted at oral treatment of rheumatoid arthritis.
展开▼
